Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Myeloid-Derived Suppressor Cells | 3 | 2021 | 316 | 0.49 | Why? |
| RNA, Ribosomal, 16S | 2 | 2021 | 793 | 0.21 | Why? |
| Killer Cells, Natural | 2 | 2020 | 2093 | 0.21 | Why? |
| Perforin | 1 | 2020 | 136 | 0.21 | Why? |
| Sirtuin 1 | 1 | 2021 | 100 | 0.20 | Why? |
| Fungemia | 1 | 2020 | 86 | 0.20 | Why? |
| Iron Overload | 1 | 2021 | 113 | 0.19 | Why? |
| Arginine | 1 | 2021 | 377 | 0.18 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2021 | 310 | 0.18 | Why? |
| Adenosine Triphosphate | 1 | 2020 | 294 | 0.18 | Why? |
| Liver Failure | 1 | 2021 | 266 | 0.17 | Why? |
| Platelet Activation | 1 | 2021 | 660 | 0.17 | Why? |
| Homeostasis | 1 | 2021 | 582 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| Nose | 1 | 2021 | 1093 | 0.14 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.13 | Why? |
| Lymphocyte Activation | 2 | 2020 | 2742 | 0.13 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.13 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.13 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.12 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Lymphocytes | 2 | 2021 | 3056 | 0.11 | Why? |
| Microbiota | 1 | 2021 | 1240 | 0.10 | Why? |
| Bacteremia | 1 | 2020 | 1372 | 0.10 | Why? |
| Liver | 2 | 2021 | 4007 | 0.10 | Why? |
| Rome | 2 | 2021 | 497 | 0.10 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Gastrointestinal Microbiome | 1 | 2021 | 1961 | 0.08 | Why? |
| Bacteria | 3 | 2021 | 1897 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.06 | Why? |
| Aged | 13 | 2021 | 215776 | 0.05 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2020 | 119 | 0.05 | Why? |
| Female | 17 | 2021 | 380317 | 0.05 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.05 | Why? |
| Male | 16 | 2021 | 367725 | 0.05 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.05 | Why? |
| Erythrocyte Indices | 1 | 2020 | 207 | 0.05 | Why? |
| Mean Platelet Volume | 1 | 2020 | 203 | 0.05 | Why? |
| Italy | 5 | 2021 | 38444 | 0.05 | Why? |
| Virulence Factors | 1 | 2021 | 338 | 0.05 | Why? |
| Transforming Growth Factor beta | 1 | 2020 | 363 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2021 | 6543 | 0.04 | Why? |
| Hepatocytes | 1 | 2021 | 549 | 0.04 | Why? |
| Bone Marrow | 1 | 2020 | 492 | 0.04 | Why? |
| Fungi | 1 | 2020 | 471 | 0.04 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Body Fluids | 1 | 2020 | 451 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Adult | 10 | 2021 | 244371 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.04 | Why? |
| Iron | 1 | 2021 | 619 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.04 | Why? |
| Humans | 19 | 2021 | 930598 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
| Liver Function Tests | 1 | 2021 | 1325 | 0.03 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Mitochondria | 1 | 2021 | 857 | 0.03 | Why? |
| Neutrophils | 2 | 2020 | 5476 | 0.03 | Why? |
| Demography | 1 | 2020 | 1660 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2021 | 1160 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.03 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.02 | Why? |
| Peptides | 1 | 2020 | 2513 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |